Virbac SA Company Top Insiders

VRBCF Stock  USD 346.00  0.00  0.00%   
Virbac SA employs about 5.1 K people. The company is managed by 10 executives with a total tenure of roughly 32 years, averaging almost 3.0 years of service per executive, having 512.0 employees per reported executive. Examination of Virbac SA's management performance can provide insight into the company performance.
Nathalie Pollet  Insider
Head Devel
Marc Bistuer  Insider
Head CEO
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virbac SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Virbac SA Management Team Effectiveness

The company has return on total asset (ROA) of 0.091 % which means that it generated a profit of $0.091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1542 %, meaning that it generated $0.1542 on every $100 dollars invested by stockholders. Virbac SA's management efficiency ratios could be used to measure how well Virbac SA manages its routine affairs as well as how well it operates its assets and liabilities.
The market capitalization of Virbac SA is $3.38 Billion. Virbac SA maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Some institutional investors establish a significant position in pink sheets such as Virbac SA in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Virbac SA, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Virbac SA Workforce Comparison

Virbac SA is rated first in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is at this time estimated at about 57,333. Virbac SA holds roughly 5,120 in number of employees claiming about 9% of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

Virbac SA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Virbac SA Price Series Summation is a cross summation of Virbac SA price series and its benchmark/peer.

Virbac SA Notable Stakeholders

A Virbac SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Virbac SA often face trade-offs trying to please all of them. Virbac SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Virbac SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Habib RamdaniCFO, Member of the Management BoardProfile
Sebastien HuronArea Director Europe, Member of the Management BoardProfile
Nathalie PolletHead DevelProfile
Marc BistuerHead CEOProfile
Sandrine BrunelHead CommunicationsProfile
Bertrand HavrileckBiologicals RDProfile
Manuela RodrguezDirector ProjectsProfile
Christian KarstExecutive Vice-Pres for Corporate Devel., General Manager, Member of the Executive Board and Member of Strategic CommitteeProfile
Francesca CortellaHead HRProfile
Sophie FaviniHead OperationsProfile
String symbol = request.getParameter("s");

About Virbac SA Management Performance

The success or failure of an entity such as Virbac SA often depends on how effective the management is. Virbac SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Virbac management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Virbac management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Virbac SA was founded in 1968 and is headquartered in Carros, France. Virbac Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 5120 people.

Virbac SA Workforce Analysis

Traditionally, organizations such as Virbac SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Virbac SA within its industry.

Virbac SA Manpower Efficiency

Return on Virbac SA Manpower

Revenue Per Employee207.8K
Revenue Per Executive106.4M
Net Income Per Employee22.1K
Net Income Per Executive11.3M

Complementary Tools for Virbac Pink Sheet analysis

When running Virbac SA's price analysis, check to measure Virbac SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virbac SA is operating at the current time. Most of Virbac SA's value examination focuses on studying past and present price action to predict the probability of Virbac SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virbac SA's price. Additionally, you may evaluate how the addition of Virbac SA to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope